Market revenue in 2024 | USD 729.8 million |
Market revenue in 2030 | USD 958.2 million |
Growth rate | 4.6% (CAGR from 2025 to 2030) |
Largest segment | Pcr-based diagnostics |
Fastest growing segment | NGS DNA Diagnosis |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays based Diagnostics, Other |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 50.73% in 2024. Horizon Databook has segmented the Japan dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays based diagnostics, other covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the most advanced countries in this region, and its market is expected to grow rapidly, due to high government spending to control cancer prevalence. The increase in cancer prevalence can be attributed to rapid growth in the geriatric population.
Japan has a median age of 44 years, one of the highest in the world. In contrast to other Asia Pacific countries, Japan offers country-wide cancer screening programs to combat its growing prevalence. These programs offer cancer screening to over 94% of the population.
However, stringent policies by regulatory agencies may delay the introduction of newer technologies in the market, which may hamper market growth during the forecast period. Several developments by market players in the country are contributing to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account